FDA Investigator Chelsea W Lamm

Chelsea W Lamm has conducted inspections on 18 sites in 4 countries as of 25 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Chelsea W Lamm's Documents

Publish Date Document Type Title
March, 2024 FDA 483 Northern Biomedical Research, Inc. - Form 483, 2024-03-29
June, 2023 FDA 483 Dennis Hammond - Form 483, 2023-06-20
October, 2023 FDA 483 Steven H. Dayan, MD - Form 483, 2023-10-06
December, 2023 FDA 483 Community Healthcare System - Form 483, 2023-12-15
May, 2023 FDA 483 Veronique Sebastian, M.D. - Form 483, 2023-05-25
November, 2023 FDA 483 Nehal J. Lakhani, M.D. - Form 483, 2023-11-17
March, 2024 FDA 483 Sagar Parikh, M.D. - Form 483, 2024-03-08
July, 2024 FDA 483 Labcorp Early Development Laboratories Inc. - Form 483, 2024-07-12
January, 2024 EIR Charles River Laboratories - EIR, 2024-02-27
November, 2024 FDA 483 EUROFINS ANIMAL HEALTH TESTING - Form 483, 2024-11-08
April, 2025 FDA 483 Labcorp Early Development Laboratories Inc. - Form 483, 2025-04-11
May, 2025 FDA 483 Scott A. Fretzin, M.D. - Form 483, 2025-05-01
May, 2025 FDA 483 Inotiv, Inc. - Form 483, 2025-05-23
February, 2025 FDA 483 Huilai Tianjin Zhang - Form 483, 2025-02-21
September, 2025 FDA 483 Rush University System for Health IRB - Form 483, 2025-09-12
September, 2023 EIR Greenfield Pathology Services, Inc. - EIR, 2023-10-10
September, 2025 FDA 483 PRA International, LLC - Form 483, 2025-09-26
November, 2025 FDA 483 TriApex Laboratories Co., Ltd. - Form 483, 2025-11-21
July, 2025 FDA 483 Center for Translational Medicine - Form 483, 2025-07-11
February, 2026 FDA 483 Stephane Leung Wai Sang, MD - Form 483, 2026-02-24
June, 2026 FDA 483 Charles River Laboratories - Form 483, 2026-06-08
June, 2026 FDA 483 Bold Advanced Medical Future (BAMF) Health - Form 483, 2026-06-25

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more